Study title: Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years’ follow-upPerindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years’ follow-up
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Cardiovascular Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: PERINDOPRIL | |||||
ATC code: | |||||
Document link: perindopril_CL3-09490-123-FRA_publication_Duboc_2007.pdf | |||||
Document date: 2011-11-07 | |||||
Study number: CL3-09490-123 (2007) | |||||
EudraCT number: | |||||
Scope of study: | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |